The biotech company SOM Biotech, based in the Barcelona Science Park and specialized in drug development and discovery, has named Alain Duguet as the new head of Chemical Manufacturing and Control. Duguet is an accredited consultant and expert in the definition, management, evaluation and optimization of the production processes of medicines for the pharmaceutical industry. He has worked in the pharmaceutical industry for over three decades for large multinationals, including Sanofi, where he led this area for over 15 years.

Alain Duguet Ph.D. has joined SOM Biotech assuming responsibility for the company´s pharmaceutical development, product manufacturing, and control and compliance with quality requirements.

Dr Duguet has extensive experience in pharmaceutical development, from the setting of analytical methods, the testing of physicochemical drug properties to the qualification of the manufacturing processes. Prior to joining SOM Biotech, he has created a successful consulting company and has served as head of Analytics and Quality Operations for large multinational pharmaceutical companies, such as Sanofi, Aventis, and Hoechst.

Raul Insa, CEO of SOM Biotech says: “I´m delighted that Alain Duguet has decided to join SOM Biotech as a Head of Chemical Manufacturing and Control at this promising time. Alain´s input will be very valuable to ensure that all stages of the drug development life cycle are correctly managed. It is crucial to ensure that the manufacturing process consistently outperforms the current standard specifications. This is of high importance specially in our clinical Phase 2 and 3 trials, where we seek to exceed the FDA and EMA regulations”.

► For further information: SOM Biotech website [+]